SequelSEC

Bausch Health Companies Inc. BHC

Pharmaceutical Preparations · CIK 0000885590 · Fiscal year ends 1231

Revenue
$11.11B
Fiscal year ended 2026-09-30
Operating income
$1.25B
Fiscal year ended 2026-09-30
Free cash flow
$1.86B
Fiscal year ended 2026-09-30

Valuation, from the filing

Public float$2.00BMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$5.41Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income12.8×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue0.2×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity5.3×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Pharmaceutical Preparations filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Long-term debt / equity54.62x100th
Effective tax rate67.3%100th
Operating margin17.7%91th
SBC / revenue2.1%11th
Current ratio1.47x20th
FCF margin9.8%79th
Net margin1.5%77th
CapEx / revenue3.9%63th
Revenue YoY growth6.7%54th

Bausch Health Companies Inc. (BHC) reported revenue of $11.11B and net income of -$841.00M for the fiscal year ended 2026-09-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Bausch Health Companies Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Bausch Health Companies Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Revenue$11.11B
Cost of revenueUnavailable
Gross profitUnavailable
Operating income$1.25B
Net income-$841.00M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income-$353.00M
Income tax expense$475.00M
Diluted EPSUnavailable
Selling, general & administrative$3.48B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Bausch Health Companies Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Cash & equivalents$2.48B
Total assets$25.48B
Current assets$7.41B
Total liabilities$25.82B
Current liabilities$4.75B
Total equity incl. NCI-$341.00M
Temporary (mezzanine) equityUnavailable
Inventory$1.59B
Accounts receivable$2.53B
Goodwill$9.77B
Long-term debt$19.77B
Accounts payable$517.00M

Cash flow

Bausch Health Companies Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Operating cash flow$2.21B
Capital expenditures$344.00M
Investing cash flow-$597.00M
Financing cash flow-$464.00M
Net change in cash$1.15B
Stock-based compensation$242.00M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$1.15B

Derived

Bausch Health Companies Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Free cash flow$1.86B
Gross marginUnavailable
Operating margin11.2%
FCF margin16.8%
SBC / revenue2.2%
Current ratio1.56x
Revenue YoY growth10.8%
Net margin-7.6%
R&D / revenueUnavailable
CapEx / revenue3.1%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BHC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-10-29View SEC filing
10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-19View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-Q · Filed 2025-07-31View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.